Profile
Ms. Sandrine Flory is a Chief Financial Officer at Institut Mérieux SA. She is on the Board of Directors at GeNeuro SA (Switzerland), Financière de Tubize SA, Transgene SA and TSGH SAS. Ms. Flory was previously employed as a Chief Financial Officer-EMEA Division by bioMérieux SA. She received her graduate degree from Universite Lumiere Lyon 2.
Sandrine Flory active positions
| Companies | Position | Start |
|---|---|---|
| TRANSGENE | Director/Board Member | 2020-12-31 |
| GENEURO SA | Director/Board Member | 2024-03-17 |
| FINANCIÈRE DE TUBIZE S.A. | Director/Board Member | 2023-12-31 |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Director of Finance/CFO | 2019-12-31 |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2001-12-31 |
Former positions of Sandrine Flory
| Companies | Position | End |
|---|---|---|
| BIOMÉRIEUX | Corporate Officer/Principal | 2019-12-31 |
Training of Sandrine Flory
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
bioMérieux SA
bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
TSGH SAS
TSGH SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Financière de Tubize SA
Financière de Tubize SA Financial ConglomeratesFinance Operates as an investment holding company which invests in the chemical, pharmaceutical and film sectors | Finance |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Universite Lumiere Lyon 2
Universite Lumiere Lyon 2 Functions as a College/University | |
GeNeuro SA (Switzerland)
GeNeuro SA (Switzerland) Engages in the research and development of pharmaceutical products to treat neurological diseases |
- Stock Market
- Insiders
- Sandrine Flory
















